- Home
- WFC vs JNJ Comparison
WFC vs JNJ Comparison
Compare WFC & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WFC | JNJ |
|---|---|---|
| Founded | 1852 | 1886 |
| Country | United States | United States |
| Employees | 200999 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.7B | 542.4B |
| IPO Year | N/A | 2003 |
Fundamental Metrics
Financial Performance| Metric | WFC | JNJ |
|---|---|---|
| Price | $84.16 | $240.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 20 |
| Target Price | $96.59 | ★ $238.20 |
| AVG Volume (30 Days) | ★ 12.4M | 7.4M |
| Earning Date | 04-14-2026 | 04-14-2026 |
| Dividend Yield | 2.21% | ★ 2.36% |
| EPS Growth | N/A | ★ 90.50 |
| EPS | N/A | ★ 2.14 |
| Revenue | N/A | N/A |
| Revenue This Year | $11.08 | $6.63 |
| Revenue Next Year | $4.76 | $7.43 |
| P/E Ratio | ★ $14.15 | $111.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $72.78 | $151.01 |
| 52 Week High | $97.76 | $251.71 |
Technical Indicators
Market Signals| Indicator | WFC | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 60.85 | 60.83 |
| Support Level | $78.04 | $233.83 |
| Resistance Level | $87.59 | $244.80 |
| Average True Range (ATR) | 1.83 | 4.73 |
| MACD | 0.24 | 0.53 |
| Stochastic Oscillator | 58.63 | 86.93 |
Price Performance
Historical ComparisonAbout WFC Wells Fargo & Company
Wells Fargo is a premier, North American-focused banking titan that commands a $2.2 trillion balance sheet and the third-highest deposit market share in the United States. The bank uses a dense, expansive network of 4,093 branches to champion retail consumers and the middle market, where the firm has built a particularly strong reputation. Following the removal of its federal asset cap in 2025, the firm is set to deploy its legacy excess liquidity to expand each of its four segments: consumer & business lending, commercial banking, corporate & investment banking, and wealth & investment management.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.